Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) will hold its 2Q20 earnings conference call with the financial community on 11th August 2020 at 8:30 AM Eastern Time.
The conference call will be webcast live on Internet at www.catalystpharma.com
Catalyst Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome in the United States. The company also develops Firdapse, which is in various clinical trials for the treatment of patients with congenital myasthenic syndrome, anti-MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3.
